益气活血化痰方干预稳定性冠心病患者炎症反应的临床研究

目的观察益气活血化痰方对稳定性冠心病患者炎症反应的抑制作用。方法60例气虚血瘀痰阻的稳定性冠心病患者随机分为对照组30例(西药常规治疗)和治疗组30例(在西药常规治疗基础上加用益气活血化痰方),疗程1个月。结果对照组和治疗组治疗前后的CD40配体(CD40L)浓度无显著性改变(P>0.05),基质金属蛋白酶9(MMP-9)差异有显著性意义(P<0.05);与对照组比较,治疗组治疗后CD40L和MMP-9均有显著性改变(P<0.05)。结论益气活血化痰方可通过降低血清CD40L、MMP-9浓度,抑制炎症反应的起始和发展,稳定动脉粥样斑块,减少冠脉事件的发生。

Clinical Study of Yiqi-huoxue and Huatan Formula on Inflammation Reactivation in Patients with Stable Coronary Heart Disease

Objective To observe the effect of Yiqi-huoxue and Huatan formula on inflammation reactivation in stable coronary heart disease(CHD).Methods 60 cases with stable CHD were randomly divided into the control group(30 cases,treated with routine therapy)and study group(30 cases,treated with routine therapy plus Yiqi-huoxue and Huatan formula).Duration was one month.Results There was no significant difference of concentration of CD40L before and after treatment in the control and study groups(P>0.05).There was a significant difference in concentration of matrix metalloproteinase-9(MMP-9)before and after treatment in the control and study groups(P<0.05).There were significant changes of CD40L and MMP-9 in the study group than in the control group(P<0.05).Conclusion Yiqi-huoxue and Huatan formula can decrease serum concentration of CD40L and MMP-9,and inhibit initiation and development of inflammation reactivation,furthermore stable atherosclerotic plaque and reduce coronary events.